Edward A. Neuwelt spends much of his time researching Surgery, Blood–brain barrier, Chemotherapy, Radiation therapy and Central nervous system. His research integrates issues of Cancer, Intraocular lymphoma and Pediatrics in his study of Surgery. His Blood–brain barrier research is multidisciplinary, incorporating perspectives in Brain tumor, Cerebrospinal fluid, Pathology and Pharmacology.
His work deals with themes such as Percent Activity, Magnetic resonance imaging, Hexosaminidase and Iron oxide nanoparticles, which intersect with Pathology. His Chemotherapy study combines topics in areas such as Survival rate, Methotrexate, Survival analysis and Toxicity. His studies in Radiation therapy integrate themes in fields like Craniotomy, Central nervous system disease, Biopsy and Lymphoma.
His scientific interests lie mostly in Pathology, Chemotherapy, Internal medicine, Blood–brain barrier and Pharmacology. His Pathology research incorporates themes from Magnetic resonance imaging and Glioma. His work focuses on many connections between Magnetic resonance imaging and other disciplines, such as Nuclear medicine, that overlap with his field of interest in Ferumoxytol.
His work carried out in the field of Chemotherapy brings together such families of science as Anesthesia and Radiation therapy. His study looks at the intersection of Internal medicine and topics like Oncology with Survival analysis. His Blood–brain barrier study integrates concerns from other disciplines, such as Neurotoxicity, Pharmacokinetics and Mannitol.
The scientist’s investigation covers issues in Internal medicine, Cancer research, Ferumoxytol, Oncology and Chemotherapy. His Ferumoxytol research is under the purview of Magnetic resonance imaging. Edward A. Neuwelt interconnects Survival analysis and Glioblastoma in the investigation of issues within Oncology.
The various areas that he examines in his Chemotherapy study include Choroidal neovascularization and Lymphoma. His Adverse effect research integrates issues from Off-label use and Surgery. As part of one scientific family, he deals mainly with the area of Central nervous system, narrowing it down to issues related to the Chemokine, and often Blood–brain barrier.
Edward A. Neuwelt mainly investigates Internal medicine, Ferumoxytol, Neuroscience, Magnetic resonance imaging and CD20. His Internal medicine study frequently draws connections between related disciplines such as Oncology. His study in Ferumoxytol is interdisciplinary in nature, drawing from both Neuroradiology, Gadoteridol, Nuclear medicine, Blood pool and Receiver operating characteristic.
Edward A. Neuwelt works in the field of Neuroscience, namely Blood–brain barrier. His Magnetic resonance imaging research includes themes of Impaired renal function and Contrast medium. His Primary central nervous system lymphoma research is within the category of Chemotherapy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy.
John R. Crossen;Dan Garwood;Eli Glatstein;Edward A. Neuwelt.
Journal of Clinical Oncology (1994)
Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma
Lauren E. Abrey;Tracy T. Batchelor;Andrés J.M. Ferreri;Mary Gospodarowicz.
Journal of Clinical Oncology (2005)
Outwitting the Blood-Brain Barrier for Therapeutic Purposes: Osmotic Opening and Other Means
Robert A. Kroll;Edward A. Neuwelt.
Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review
Jason S Weinstein;Csanad G Varallyay;Edit Dosa;Seymur Gahramanov.
Journal of Cerebral Blood Flow and Metabolism (2010)
Engaging neuroscience to advance translational research in brain barrier biology
Edward A. Neuwelt;Björn Bauer;Christoph Fahlke;Gert Fricker.
Nature Reviews Neuroscience (2011)
Long-circulating iron oxides for MR imaging
Ralph Weissleder;Alexei Bogdanov;Edward A. Neuwelt;Mikhail Papisov.
Advanced Drug Delivery Reviews (1995)
Ototoxicity in Children Receiving Platinum Chemotherapy: Underestimating a Commonly Occurring Toxicity That May Influence Academic and Social Development
Kristin R. Gilmer Knight;Dale F. Kraemer;Edward A. Neuwelt.
Journal of Clinical Oncology (2005)
Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors
Nancy D. Doolittle;Michael E. Miner;Walter A. Hall;Tali Siegal.
Strategies to advance translational research into brain barriers
Edward Neuwelt;N Joan Abbott;Lauren Abrey;William A Banks.
Lancet Neurology (2008)
Chemotherapy delivery issues in central nervous system malignancy: a reality check.
Leslie L. Muldoon;Carole Soussain;Kristoph Jahnke;Conrad Johanson.
Journal of Clinical Oncology (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: